Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Biogen Pharmachem Industries Ltd has informed BSE that a meeting of its Board of Directors is scheduled for 14th May 2026. The meeting will consider and approve the Audited Standalone Financial Results for the quarter and year ended 31st March 2026, along with the Auditors' Reports. This is a standard regulatory intimation under SEBI (LODR) Regulations, 2015. The company is listed on BSE with Scrip Code 531752. This is not the actual results announcement but merely a pre-disclosure notice.
This is a routine procedural filing. The actual financial results when announced will provide more insight into the company's performance for Q4 FY2026. Shareholders should await the results announcement expected after 14th May 2026.